Drug Safety Project

Research & Analysis

View All
  • Letter in Support of FDA Enforcement of Compounding Law

    On November 20, The Pew Charitable Trusts—joined by the American Public Health Association, the Biotechnology Industry Organization, the Generic Pharmaceutical Association, the Pharmaceutical Research and Manufacturers of America, and Trust for America’s Health—sent a letter to the Food and Drug Administration (FDA) supporting their enforcement of federal law on drug... Read More

  • Pharmacy Implementation of the Drug Supply Chain Security Act

    The Drug Supply Chain Security Act (DSCSA) of 2013 created a national system in which companies involved in pharmaceutical distribution work together to safeguard the U.S. pharmaceutical supply and protect consumers from compromised or counterfeit drugs. Pharmacies play a critical role in preventing unsafe products from reaching consumers. Read More

  • Pew and Partners Comment on FDA’s Suspect Product Guidance

    On Monday, August 11, The Pew Charitable Trusts submitted comments on draft guidance documents from the U.S. Food and Drug Administration on how supply chain partners will identify and notify other partners of “suspect product,” part of Title II of the Drug Quality and Security Act, Drug Supply Chain Security Act. Read More

Media Contact

Linda Paris

Officer, Communications